Document
IPR2016-01332, No. 2003-5 Exhibit - JSN 2003 Bindu Donovan in Support of Motion to Appear Pro Hac Vice (P.T.A.B. Oct. 12, 2016)
Cite Document
IPR2016-01332, No. 2003-5 Exhibit - JSN 2003 Bindu Donovan in Support of Motion to Appear Pro Hac Vice (P.T.A.B. Oct. 12, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1021 Exhibit - Oh 2002 (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1021 Exhibit - Oh 2002 (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1064 Exhibit - Zytiga Brochure (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1064 Exhibit - Zytiga Brochure (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1040 Exhibit - Cancernet (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1040 Exhibit - Cancernet (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 2073-80 Exhibit - JSN 2073 Tokai July 26, 2016 Press Release (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2073-80 Exhibit - JSN 2073 Tokai July 26, 2016 Press Release (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2136-131 Exhibit - JSN 2136 BTG Webpage from WayBack Machine (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2136-131 Exhibit - JSN 2136 BTG Webpage from WayBack Machine (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2142-137 Exhibit - JSN 2142 JJ Q4 2013 Earnings Call Transcript (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2142-137 Exhibit - JSN 2142 JJ Q4 2013 Earnings Call Transcript (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1024 Exhibit - Hellerstedt 2002 (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1024 Exhibit - Hellerstedt 2002 (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1101-168 Exhibit - Osoba 1999 (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01332, No. 1101-168 Exhibit - Osoba 1999 (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1124-190 Exhibit - Scher 2008 (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01332, No. 1124-190 Exhibit - Scher 2008 (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2128-123 Exhibit - JSN 2128 Deposition Transcript of Ivan T Hofmann, taken by Patent Owner on February 7, 2017 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2128-123 Exhibit - JSN 2128 Deposition Transcript of Ivan T Hofmann, taken by Patent Owner on February 7, 2017 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2033-41 Exhibit - JSN 2033 Press Release 1262016 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2033-41 Exhibit - JSN 2033 Press Release 1262016 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1013 Exhibit - July 3, 2012 Notice of Allowance (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1013 Exhibit - July 3, 2012 Notice of Allowance (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1116-182 Exhibit - Berry 2002 (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01332, No. 1116-182 Exhibit - Berry 2002 (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2009-16 Exhibit - JSN 2009 Garnick Deposition Ex 1 ¿¿¿ Bubley et al, ¿¿¿Eligibility and Response Guidelines for Phase II Clinical Trials (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2009-16 Exhibit - JSN 2009 Garnick Deposition Ex 1 ¿¿¿ Bubley et al, ¿¿¿Eligibility and Response Guidelines for Phase II Clinical Trials (P.T.A.B. Mar. 8, 2017)
+ More Snippets